References
- Appelbaum, F.R. (2001). Haematopoietic cell transplantation as immunotherapy. Nature 411, 385-389. https://doi.org/10.1038/35077251
- Asprodites, N., Zheng, L., Geng, D., Velasco-Gonzalez, C., Sanchez-Perez, L., and Davila, E. (2008). Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity. FASEB J. 22, 3628-3637. https://doi.org/10.1096/fj.08-108274
- Barrett, A.J. (1997). Mechanisms of the graft-versus-leukemia reaction. Stem Cells 15, 248-258. https://doi.org/10.1002/stem.150248
- Bendigs, S., Salzer, U., Lipford, G.B., Wagner, H., and Heeg, K. (1999). CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells. Eur. J. Immunol. 29, 1209-1218. https://doi.org/10.1002/(SICI)1521-4141(199904)29:04<1209::AID-IMMU1209>3.0.CO;2-J
- Caron, G., Duluc, D., Fremaux, I., Jeannin, P., David, C., Gascan, H., and Delneste, Y. (2005). Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells. J. Immunol. 175, 1551-1557. https://doi.org/10.4049/jimmunol.175.3.1551
- Chang, J., Burkett, P.R., Borges, C.M., Kuchroo, V.K., Turka, L.A., and Chang, C.H. (2013). MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling. Proc. Natl. Acad. Sci. USA 110, 2270-2275. https://doi.org/10.1073/pnas.1206048110
- Cooke, K. R., Hill, G. R., Crawford, J. M., Bungard, D., Brinson, Y. S., Delmonte, J., Jr., and Ferrara, J.L. (1998). Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J. Clin. Invest. 102, 1882-1891. https://doi.org/10.1172/JCI4285
- Cottalorda, A., Verschelde, C., Marcais, A., Tomkowiak, M., Musette, P., Uematsu, S., Akira, S., Marvel, J., and Bonnefoy-Berard, N. (2006). TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation. Eur. J. Immunol. 36, 1684-1693. https://doi.org/10.1002/eji.200636181
- Dudley, M.E., Wunderlich, J.R., Yang, J.C., Sherry, R.M., Topalian, S.L., Restifo, N.P., Royal, R.E., Kammula, U., White, D.E., Mavroukakis, S.A., et al. (2005). Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J. Clin. Oncol. 23, 2346-2357. https://doi.org/10.1200/JCO.2005.00.240
- Fukata, M., Breglio, K., Chen, A., Vamadevan, A.S., Goo, T., Hsu, D., Conduah, D., Xu, R., and Abreu, M.T. (2008). The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. J. Immunol. 180, 1886-1894. https://doi.org/10.4049/jimmunol.180.3.1886
- Gelman, A.E., Zhang, J., Choi, Y., and Turka, L.A. (2004). Toll-like receptor ligands directly promote activated CD4+ T cell survival. J. Immunol. 172, 6065-6073. https://doi.org/10.4049/jimmunol.172.10.6065
- Hartman, Z.C., Osada, T., Glass, O., Yang, X.Y., Lei, G.J., Lyerly, H.K., and Clay, T.M. (2010). Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity. Cancer Res. 70, 7209-7220. https://doi.org/10.1158/0008-5472.CAN-10-0905
- Hill, G.R., and Ferrara, J.L. (2000). The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 95, 2754-2759.
- Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., et al. (1990). Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75, 555-562.
- Kawai, T., Adachi, O., Ogawa, T., Takeda, K., and Akira, S. (1999). Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122. https://doi.org/10.1016/S1074-7613(00)80086-2
- Komai-Koma, M., Jones, L., Ogg, G.S., Xu, D., Liew, F.Y. (2004). TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl. Acad. Sci. USA 101, 3029-3034. https://doi.org/10.1073/pnas.0400171101
- Lim, J.Y., Choi, M.S., Youn, H., Choi, E.Y., and Min, C.K. (2011). The influence of pretransplantation conditioning on graft-vs.-leukemia effect in mice. Exp. Hematol. 39, 1018-1029. https://doi.org/10.1016/j.exphem.2011.07.003
- Lim, J.Y., Cho, B.S., Min, C.K., Park, G., Kim, Y.J., Chung, N.G., Jeong, D.C., and Min, W.S. (2014). Fluctuations in pathogenic CD4+ T-cell subsets in a murine sclerodermatous model of chronic graft-versus-host disease. Immunol. Invest. 43, 41-53. https://doi.org/10.3109/08820139.2013.843191
- Min, C.K., Maeda, Y., Lowler, K., Liu, C., Clouthier, S., Lofthus, D., Weisiger, E., Ferrara, J.L., and Reddy, P. (2004). Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation. Blood 104, 3393-3399. https://doi.org/10.1182/blood-2004-02-0763
- Schmaltz, C., Alpdogan, O., Horndasch, K.J., Muriglan, S.J., Kappel, B.J., Teshima, T., Ferrara, J.L., Burakoff, S.J., and van den Brink, M.R. (2001). Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood 97, 2886-2895. https://doi.org/10.1182/blood.V97.9.2886
- Schmaltz, C., Alpdogan, O., Muriglan, S.J., Kappel, B.J., Rotolo, J.A., Ricchetti, E.T., Greenberg, A.S., Willis, L.M., Murphy, G.F., Crawford, J.M., et al. (2003). Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation. Blood 101, 2440-2445. https://doi.org/10.1182/blood-2002-07-2109
- Schnare, M., Barton, G.M., Holt, A.C., Takeda, K., Akira, S., and Medzhitov, R. (2001). Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2, 947-950. https://doi.org/10.1038/ni712
- Shin, H.J., Baker, J., Leveson-Gower, D.B., Smith, A.T., Sega, E.I., and Negrin, R.S. (2011). Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. Blood 118, 2342-2350. https://doi.org/10.1182/blood-2010-10-313684
- Taylor, P.A., Lees, C.J., and Blazar, B.R. (2002). The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99, 3493-3499. https://doi.org/10.1182/blood.V99.10.3493
- Teshima, T., Hill, G.R., Pan, L., Brinson, Y.S., van den Brink, M.R., Cooke, K.R., and Ferrara, J.L. (1999). IL-11 separates graft-versus- leukemia effects from graft-versus-host disease after bone marrow transplantation. J. Clin. Invest. 104, 317-325. https://doi.org/10.1172/JCI7111
- Tomita, T., Kanai, T., Fujii, T., Nemoto, Y., Okamoto, R., Tsuchiya, K., Totsuka, T., Sakamoto, N., Akira, S., and Watanabe, M. (2008). MyD88-dependent pathway in T cells directly modulates the expansion of colitogenic CD4+ T cells in chronic colitis. J. Immunol. 180, 5291-5299. https://doi.org/10.4049/jimmunol.180.8.5291
- van den Brink, M.R., and Burakoff, S.J. (2002). Cytolytic pathways in haematopoietic stem-cell transplantation. Nat. Rev. Immunol. 2, 273-281. https://doi.org/10.1038/nri775
- Wu, H., Chen, G., Wyburn, K.R., Yin, J., Bertolino, P., Eris, J.M., Alexander, S.I., Sharland, A.F., and Chadban, S.J. (2007). TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117, 2847-2859. https://doi.org/10.1172/JCI31008
- Wysocki, C. A., Panoskaltsis-Mortari, A., Blazar, B. R., and Serody, J. S. (2005). Leukocyte migration and graft-versus-host disease. Blood 105, 4191-4199. https://doi.org/10.1182/blood-2004-12-4726
- Yang, Y.G., Sergio, J.J., Pearson, D.A., Szot, G.L., Shimizu, A., and Sykes, M. (1997). Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood 90, 4651-4660.
- Yang, Y.G., Qi, J., Wang, M.G., and Sykes, M. (2002). Donorderived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells. Blood 99, 4207-4215. https://doi.org/10.1182/blood.V99.11.4207
- Zheng, L., Asprodites, N., Keene, A.H., Rodriguez, P., Brown, K.D., and Davila, E. (2008). TLR9 engagement on CD4 T lymphocytes represses gamma-radiation-induced apoptosis through activation of checkpoint kinase response elements. Blood 111, 2704-2713. https://doi.org/10.1182/blood-2007-07-104141
Cited by
- Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives vol.7, 2016, https://doi.org/10.3389/fimmu.2016.00539
- Role of Toll-Like Receptor Signaling in the Pathogenesis of Graft-versus-Host Diseases vol.17, pp.8, 2016, https://doi.org/10.3390/ijms17081288
- Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation vol.52, pp.4, 2017, https://doi.org/10.1038/bmt.2016.263
- Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease vol.9, pp.None, 2018, https://doi.org/10.3389/fimmu.2018.03041
- Myeloid differentiation factor 88 signaling in donor T cells accelerates graft-versus-host disease vol.105, pp.1, 2015, https://doi.org/10.3324/haematol.2018.203380
- MyD88 Costimulation in Donor CD8+ T Cells Enhances the Graft-versus-Tumor Effect in Murine Hematopoietic Cell Transplantation vol.206, pp.4, 2021, https://doi.org/10.4049/jimmunol.2000479